Clinical trial
Metformin Efficacy and Safety in Epileptic Patients
NCT05722951 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin Efficacy and Safety in Epileptic Patients
- Lead sponsor
- Tanta University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 18, 2022
- Completion date
- June 20, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.